These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24205049)

  • 1. Rational design, synthesis, and biological evaluation of third generation α-noscapine analogues as potent tubulin binding anti-cancer agents.
    Manchukonda NK; Naik PK; Santoshi S; Lopus M; Joseph S; Sridhar B; Kantevari S
    PLoS One; 2013; 8(10):e77970. PubMed ID: 24205049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
    Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
    J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid.
    Naik PK; Chatterji BP; Vangapandu SN; Aneja R; Chandra R; Kanteveri S; Joshi HC
    J Comput Aided Mol Des; 2011 May; 25(5):443-54. PubMed ID: 21544622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
    Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
    J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
    Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
    Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of 9-vinyl-phenyl noscapine as potent tubulin binding anticancer agent and evaluation of the effects of its combination on Docetaxel.
    Dash SG; Suri C; Nagireddy PKR; Kantevari S; Naik PK
    J Biomol Struct Dyn; 2021 Sep; 39(14):5276-5289. PubMed ID: 32608323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of novel N-alkyl amine analogues of noscapine, their chemical synthesis and cellular activity as potent anticancer agents.
    Meher RK; Pragyandipta P; Pedapati RK; Nagireddy PKR; Kantevari S; Nayek AK; Naik PK
    Chem Biol Drug Des; 2021 Sep; 98(3):445-465. PubMed ID: 34051055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells.
    Patel AK; Meher RK; Nagireddy PK; Pragyandipta P; Pedapati RK; Kantevari S; Naik PK
    SAR QSAR Environ Res; 2021 Apr; 32(4):269-291. PubMed ID: 33687299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents.
    Patel AK; Meher RK; Reddy PK; Pedapati RK; Pragyandipta P; Kantevari S; Naik MR; Naik PK
    J Mol Graph Model; 2021 Jul; 106():107933. PubMed ID: 33991960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative Noscapinoids Bearing an Amidothiadiazole Scaffold as Apoptosis Inducers: Design, Synthesis and Molecular Docking.
    Kumar Pedapati R; Pragyandipta P; Pranathi Abburi N; Chirra N; Kantevari S; Naik PK
    Chem Biodivers; 2023 Feb; 20(2):e202201089. PubMed ID: 36690497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation.
    Ghaly PE; Abou El-Magd RM; Churchill CD; Tuszynski JA; West FG
    Oncotarget; 2016 Jun; 7(26):40518-40530. PubMed ID: 27777381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cells.
    Dash SG; Kantevari S; Pandey SK; Naik PK
    Chem Biol Drug Des; 2021 Sep; 98(3):466-479. PubMed ID: 34107169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined molecular dynamics and continuum solvent approaches (MM-PBSA/GBSA) to predict noscapinoid binding to γ-tubulin dimer.
    Suri C; Naik PK
    SAR QSAR Environ Res; 2015 Jun; 26(6):507-19. PubMed ID: 26274780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modelling and competition binding study of Br-noscapine and colchicine provide insight into noscapinoid-tubulin binding site.
    Naik PK; Santoshi S; Rai A; Joshi HC
    J Mol Graph Model; 2011 Jun; 29(7):947-55. PubMed ID: 21530342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis of Noscapine Activation for Tubulin Binding.
    Oliva MA; Prota AE; Rodríguez-Salarichs J; Bennani YL; Jiménez-Barbero J; Bargsten K; Canales Á; Steinmetz MO; Díaz JF
    J Med Chem; 2020 Aug; 63(15):8495-8501. PubMed ID: 32657585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer.
    Meher RK; Pragyandipta P; Reddy PK; Pedaparti R; Kantevari S; Naik PK
    J Biomol Struct Dyn; 2022; 40(23):13136-13153. PubMed ID: 34583618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insight of isotypes specific β-tubulin interaction of tubulin heterodimer with noscapinoids.
    Santoshi S; Naik PK
    J Comput Aided Mol Des; 2014 Jul; 28(7):751-63. PubMed ID: 24916062
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Meher RK; Nagireddy PKR; Pragyandipta P; Kantevari S; Singh SK; Kumar V; Naik PK
    J Biomol Struct Dyn; 2022 Sep; 40(15):6725-6736. PubMed ID: 33627059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
    Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
    Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids.
    Santoshi S; Naik PK; Joshi HC
    J Biomol Screen; 2011 Oct; 16(9):1047-58. PubMed ID: 21972248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.